Academic Journal
أعرض في EDS

Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
المؤلفون: Pedrani, M., Salfi, G., Merler, S., Testi, I., Cani, M., Turco, F., Trevisi, E., Tortola, L., Treglia, G., Di Tanna, G.L., Vogl, U., Gillessen, S., Theurillat, J.P., Pereira Mestre, R.
المصدر: European urology oncology, vol. 7, no. 6, pp. 1199-1215
سنة النشر: 2024
المجموعة: Université de Lausanne (UNIL): Serval - Serveur académique lausannois
مصطلحات موضوعية: Humans, Male, Prostatic Neoplasms/genetics, Prostatic Neoplasms/pathology, Prostatic Neoplasms/therapy, Prostatic Neoplasms/mortality, Prostatic Neoplasms/drug therapy, Repressor Proteins/genetics, Nuclear Proteins/genetics, Mutation, Prognosis, Abiraterone, Androgen deprivation treatment, Docetaxel, Meta-analysis, Predictive, Prostate cancer, Speckle-type POZ, Survival, Systematic review
الوصف: Mutations in the speckle-type POZ (SPOP) gene are frequently identified in prostate cancer (PC); yet, prognostic implications for affected patients remain unclear. Limited consensus exists regarding tailored treatments for SPOP-mutant (SPOPmut) PC. To elucidate the prognostic and predictive significance of SPOP mutations across distinct PC stages and treatments. A systematic literature search of PubMed, Embase, and Scopus was conducted up to January 29, 2024. The meta-analysis included studies comparing survival outcomes between SPOPmut and SPOP wild-type (SPOPwt) PC. From 669 records, 26 studies (including five abstracts) were analyzed. A meta-analysis of metastasis-free survival in localized (hazard ratio [HR]: 0.72, 95% confidence interval [CI]: 0.59-0.88; p < 0.01) and overall survival (OS) in metastatic PC (HR: 0.64, 95% CI: 0.53-0.76; p < 0.01) showed a favorable prognosis for patients with SPOPmut PC. In metastatic settings, SPOP mutations correlated with improved progression-free survival (PFS) and OS in patients undergoing androgen deprivation therapy ± androgen receptor signaling inhibitor (HR: 0.51, 95% CI: 0.35-0.76, p < 0.01, and HR: 0.60, 95% CI:0.46-0.79, p < 0.01, respectively). In metastatic castration-resistant PC, only abiraterone provided improved PFS and OS to patients with SPOP mutations compared with patients with SPOPwt, but data were limited. SPOP mutations did not correlate with improved PFS (p = 0.80) or OS (p = 0.27) for docetaxel. Patients with SPOPmut PC seem to exhibit superior oncological outcomes compared with patients with SPOPwt. Tailored risk stratification and treatment approaches should be explored in such patients. Speckle-type POZ (SPOP) mutations could be a favorable prognostic factor in patients with prostate cancer (PC) and may also predict better progression-free and overall survival than treatment with hormonal agents. Therefore, less intensified treatments omitting chemotherapy for patients with SPOP-mutant PC should be explored in ...
نوع الوثيقة: article in journal/newspaper
review
وصف الملف: application/pdf
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/38704358; info:eu-repo/semantics/altIdentifier/eissn/2588-9311; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_18369D0EF1D25; https://serval.unil.ch/notice/serval:BIB_18369D0EF1D2; https://serval.unil.ch/resource/serval:BIB_18369D0EF1D2.P001/REF.pdf
DOI: 10.1016/j.euo.2024.04.011
الاتاحة: https://serval.unil.ch/notice/serval:BIB_18369D0EF1D2
https://doi.org/10.1016/j.euo.2024.04.011
https://serval.unil.ch/resource/serval:BIB_18369D0EF1D2.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_18369D0EF1D25
Rights: info:eu-repo/semantics/openAccess ; CC BY-NC-ND 4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.3BF01A0C
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.3BF01A0C
910
3
Academic Journal
academicJournal
910.377258300781
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.3BF01A0C&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://serval.unil.ch/notice/serval:BIB_18369D0EF1D2# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pedrani%2C+M%2E%22&quot;&gt;Pedrani, M.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Salfi%2C+G%2E%22&quot;&gt;Salfi, G.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Merler%2C+S%2E%22&quot;&gt;Merler, S.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Testi%2C+I%2E%22&quot;&gt;Testi, I.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Cani%2C+M%2E%22&quot;&gt;Cani, M.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Turco%2C+F%2E%22&quot;&gt;Turco, F.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Trevisi%2C+E%2E%22&quot;&gt;Trevisi, E.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Tortola%2C+L%2E%22&quot;&gt;Tortola, L.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Treglia%2C+G%2E%22&quot;&gt;Treglia, G.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Di+Tanna%2C+G%2EL%2E%22&quot;&gt;Di Tanna, G.L.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Vogl%2C+U%2E%22&quot;&gt;Vogl, U.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gillessen%2C+S%2E%22&quot;&gt;Gillessen, S.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Theurillat%2C+J%2EP%2E%22&quot;&gt;Theurillat, J.P.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pereira+Mestre%2C+R%2E%22&quot;&gt;Pereira Mestre, R.&lt;/searchLink&gt; )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => European urology oncology, vol. 7, no. 6, pp. 1199-1215 )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2024 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Universit&#233; de Lausanne (UNIL): Serval - Serveur acad&#233;mique lausannois )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Humans%22&quot;&gt;Humans&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Male%22&quot;&gt;Male&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%2Fgenetics%22&quot;&gt;Prostatic Neoplasms/genetics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%2Fpathology%22&quot;&gt;Prostatic Neoplasms/pathology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%2Ftherapy%22&quot;&gt;Prostatic Neoplasms/therapy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%2Fmortality%22&quot;&gt;Prostatic Neoplasms/mortality&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostatic+Neoplasms%2Fdrug+therapy%22&quot;&gt;Prostatic Neoplasms/drug therapy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Repressor+Proteins%2Fgenetics%22&quot;&gt;Repressor Proteins/genetics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Nuclear+Proteins%2Fgenetics%22&quot;&gt;Nuclear Proteins/genetics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mutation%22&quot;&gt;Mutation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prognosis%22&quot;&gt;Prognosis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Abiraterone%22&quot;&gt;Abiraterone&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Androgen+deprivation+treatment%22&quot;&gt;Androgen deprivation treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Docetaxel%22&quot;&gt;Docetaxel&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Meta-analysis%22&quot;&gt;Meta-analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Predictive%22&quot;&gt;Predictive&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prostate+cancer%22&quot;&gt;Prostate cancer&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Speckle-type+POZ%22&quot;&gt;Speckle-type POZ&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Survival%22&quot;&gt;Survival&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Systematic+review%22&quot;&gt;Systematic review&lt;/searchLink&gt; )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Mutations in the speckle-type POZ (SPOP) gene are frequently identified in prostate cancer (PC); yet, prognostic implications for affected patients remain unclear. Limited consensus exists regarding tailored treatments for SPOP-mutant (SPOPmut) PC. To elucidate the prognostic and predictive significance of SPOP mutations across distinct PC stages and treatments. A systematic literature search of PubMed, Embase, and Scopus was conducted up to January 29, 2024. The meta-analysis included studies comparing survival outcomes between SPOPmut and SPOP wild-type (SPOPwt) PC. From 669 records, 26 studies (including five abstracts) were analyzed. A meta-analysis of metastasis-free survival in localized (hazard ratio [HR]: 0.72, 95% confidence interval [CI]: 0.59-0.88; p &lt; 0.01) and overall survival (OS) in metastatic PC (HR: 0.64, 95% CI: 0.53-0.76; p &lt; 0.01) showed a favorable prognosis for patients with SPOPmut PC. In metastatic settings, SPOP mutations correlated with improved progression-free survival (PFS) and OS in patients undergoing androgen deprivation therapy &#177; androgen receptor signaling inhibitor (HR: 0.51, 95% CI: 0.35-0.76, p &lt; 0.01, and HR: 0.60, 95% CI:0.46-0.79, p &lt; 0.01, respectively). In metastatic castration-resistant PC, only abiraterone provided improved PFS and OS to patients with SPOP mutations compared with patients with SPOPwt, but data were limited. SPOP mutations did not correlate with improved PFS (p = 0.80) or OS (p = 0.27) for docetaxel. Patients with SPOPmut PC seem to exhibit superior oncological outcomes compared with patients with SPOPwt. Tailored risk stratification and treatment approaches should be explored in such patients. Speckle-type POZ (SPOP) mutations could be a favorable prognostic factor in patients with prostate cancer (PC) and may also predict better progression-free and overall survival than treatment with hormonal agents. Therefore, less intensified treatments omitting chemotherapy for patients with SPOP-mutant PC should be explored in ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper&lt;br /&gt;review )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/38704358; info:eu-repo/semantics/altIdentifier/eissn/2588-9311; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_18369D0EF1D25; https://serval.unil.ch/notice/serval:BIB_18369D0EF1D2; https://serval.unil.ch/resource/serval:BIB_18369D0EF1D2.P001/REF.pdf )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/j.euo.2024.04.011 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://serval.unil.ch/notice/serval:BIB_18369D0EF1D2&lt;br /&gt;https://doi.org/10.1016/j.euo.2024.04.011&lt;br /&gt;https://serval.unil.ch/resource/serval:BIB_18369D0EF1D2.P001/REF.pdf&lt;br /&gt;http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_18369D0EF1D25 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/openAccess ; CC BY-NC-ND 4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0/ )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.3BF01A0C )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1016/j.euo.2024.04.011 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Humans [Type] => general ) [1] => Array ( [SubjectFull] => Male [Type] => general ) [2] => Array ( [SubjectFull] => Prostatic Neoplasms/genetics [Type] => general ) [3] => Array ( [SubjectFull] => Prostatic Neoplasms/pathology [Type] => general ) [4] => Array ( [SubjectFull] => Prostatic Neoplasms/therapy [Type] => general ) [5] => Array ( [SubjectFull] => Prostatic Neoplasms/mortality [Type] => general ) [6] => Array ( [SubjectFull] => Prostatic Neoplasms/drug therapy [Type] => general ) [7] => Array ( [SubjectFull] => Repressor Proteins/genetics [Type] => general ) [8] => Array ( [SubjectFull] => Nuclear Proteins/genetics [Type] => general ) [9] => Array ( [SubjectFull] => Mutation [Type] => general ) [10] => Array ( [SubjectFull] => Prognosis [Type] => general ) [11] => Array ( [SubjectFull] => Abiraterone [Type] => general ) [12] => Array ( [SubjectFull] => Androgen deprivation treatment [Type] => general ) [13] => Array ( [SubjectFull] => Docetaxel [Type] => general ) [14] => Array ( [SubjectFull] => Meta-analysis [Type] => general ) [15] => Array ( [SubjectFull] => Predictive [Type] => general ) [16] => Array ( [SubjectFull] => Prostate cancer [Type] => general ) [17] => Array ( [SubjectFull] => Speckle-type POZ [Type] => general ) [18] => Array ( [SubjectFull] => Survival [Type] => general ) [19] => Array ( [SubjectFull] => Systematic review [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pedrani, M. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Salfi, G. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Merler, S. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Testi, I. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cani, M. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Turco, F. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Trevisi, E. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tortola, L. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Treglia, G. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Di Tanna, G.L. ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vogl, U. ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gillessen, S. ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Theurillat, J.P. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pereira Mestre, R. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2024 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => European urology oncology, vol. 7, no. 6, pp. 1199-1215 [Type] => main ) ) ) ) ) ) )
IllustrationInfo